ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ruella, M. [1 ]
Shestova, O. [1 ]
Kenderian, S. [1 ]
Barrett, D. [2 ]
Grupp, S. [2 ]
Scholler, J. [1 ]
Lacey, S. [1 ]
Kalos, M. [1 ]
June, C. H. [1 ]
Gill, S. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2014年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jcyt.2014.01.017
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
5
引用
下载
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia
    Ding, Zhi-Chun
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
  • [2] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03): : 191 - 198
  • [3] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    del Bufalo, Francesca
    Quintarelli, Concetta
    HAEMATOLOGICA, 2024, 109 (06) : 1689 - 1699
  • [4] Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Tomuleasa, Ciprian
    Fuji, Shigeo
    Berce, Cristian
    Onaciu, Anca
    Chira, Sergiu
    Petrushev, Bobe
    Micu, Wilhelm-Thomas
    Moisoiu, Vlad
    Osan, Ciprian
    Constantinescu, Catalin
    Pasca, Sergiu
    Jurj, Ancuta
    Pop, Laura
    Berindan-Neagoe, Ioana
    Dima, Delia
    Kitano, Shigehisa
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for Adult Patients with Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia
    Huang, Liang
    Wang, Na
    Li, Chunrui
    Cao, Yang
    Xiao, Yi
    Xiao, Min
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    BLOOD, 2017, 130
  • [6] EFFECTIVE TARGETING OF PRIMARY HUMAN ACUTE MYELOID LEUKEMIA USING ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR ENGINEERED T CELLS
    Gill, S.
    Tasian, S. K.
    Scholler, J.
    Porter, D. L.
    Carroll, M. P.
    Grupp, S. A.
    June, C.
    Kalos, M.
    CYTOTHERAPY, 2013, 15 (04) : S13 - S14
  • [7] Anti-CD123 Chimeric Antigen Receptor Natural Killer cell therapy to treat Acute Myeloid Leukemia.
    Kizerwetter, Monika
    Yang, Huilin
    Rahnama, Ruyan
    Bonifant, Challice
    Spangler, Jamie
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [8] CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
    Tasian, Sarah K.
    Gardner, Rebecca A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (05) : 228 - 241
  • [9] Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia
    Wang, Xiangmin
    Zhang, Bingpei
    Zhang, Qing
    Zhou, Hongyuan
    Sun, Qian
    Zhou, Yi
    Li, Tianci
    Zhou, Dian
    Shen, Ziyuan
    Zhang, Jiaoli
    Li, Ping
    Liang, Aibin
    Zhou, Keshu
    Han, Lu
    Hu, Yongxian
    Yang, Yun
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    Sang, Wei
    CANCER, 2024, 130 (15) : 2660 - 2669
  • [10] Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
    Arcangeli, Silvia
    Rotiroti, Maria Caterina
    Bardelli, Marco
    Simonelli, Luca
    Magnani, Chiara Francesca
    Biondi, Andrea
    Biagi, Ettore
    Tettamanti, Sarah
    Varani, Luca
    MOLECULAR THERAPY, 2017, 25 (08) : 1933 - 1945
12345